• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/24

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

24 Cards in this Set

  • Front
  • Back
Parkinson's Drugs
Levodopa, Ropinirole
Carbidopa/levodopa Amantadine
Selegiline Benztropine
Bromocriptine
Pramipexole
Alzheimer's disease
Donepezil
Memantine
L-Dopa
L-dopa crosses teh blood brain barrier and is a precursor of Dopamine synthesis
monotherapy results in peripheral side effects: Nausea and vomiting
L-Dopa/Carbidopa
When L-Dopa is combined with carbidopa, peripheral side effects are reduced
Carbidopa is a dopa decarboxylase inhibitor does not cross the Blood Brain Barrier
L-Dopa/Carbidopa

Pharmacokinetics
1) Given orally
2) Aminoacids will compete for absorption
3) Short half life
L-Dopa/Carbidopa

Uses
1) Bradykinesia of parkinson's
2) Effectiveness decreases over time due to reduction in dopaminergic neurons
L-Dopa/Carbidopa

Side effects GI
1) Nausea and vomiting
2) Develop tolerance after a few months
L-Dopa/Carbidopa

Side effects Cardiovascular
1) postural hypotension
2) Hypertension when combined with MAOI
L-Dopa/Carbidopa

Side effects Dyskinesias
1) Excessive involuntary movements
2) Develop over time
3) Lowering dose decreases dyskinesia but also reduces mobility
L-Dopa/Carbidopa

side effects Behavioral
1) Depression anxiety agitation
2) Insomnia somnolence
3) Confusion, delusions, hallucinations
4) Psychosis treated with clozapine, quetiapine, or aripiprazole
L-Dopa/Carbidopa

On/Off phenomenon
1) Only with L-Dopa
2) adaptation to treatment
3) "off" periods of akinesia
Tx: Increase frequency of administration, decrease dietary amino acids, or selegiline (dopamine agonist)
L-Dopa/Carbidopa

Drug holiday
Abrupt withdrawal of drug causes: akinesia or neuroleptic malignant syndrome.

Dangerous don't do it
L-Dopa/Carbidopa

Drug interactions
MAOI- Hypertension
Pyridoxine(B6)->increases peripheral metabolism
L-Dopa/Carbidopa

Contraindications
1) Psychosis
2) Closed angle glaucoma
3) Cardiac disease
4) Active peptic ulcer
5) Malignant melanoma
Selegiline
1) Inhibits MAO-B in striatum,
2) Decreases free radicals
Side effects
1) Do not combine with Meperidine, TCAs or SSRI may cause stupor, rigidity agitation and hyperthermia.
Bromocriptine
Dopamine agonist
1) Acts directly on receptors
2) Does not decrease in efficiency as disease progresses
3) Ergot derivative = vasospasm
4) Decrease release of prolactin
Bromocriptine Side effects
1) GI: Nausea vomiting, anorexia
2) Cardio: Postural hypotension, arrythmias
3) Dyskinesia
4) Mental disturbance
5) Erythromelalgia: red tender swollen feet due to vasospasm
Pramipexole/ Ropinirole
Dopamine agonist
1) Do not cause Erythromyalgia, vasospasm, or fibrosis
2) Well tolerated
3) Less on and off phenomenon
Amantadine
Antiviral, may increase dopamine release.
Side effects:
1) Toxic psychosis, convulsions
2) Spotting of skin (livedo reticularis)
3) Peripheral edema:
Contraindicated:
1) History of seizures
2) Congestive heart failure
Benztropine
Anticholinergic
1) Improves rigidity or tremors, drooling
2) Decrease effects of cholinergic drugs to match loss of dopamine
3) diphenhydramine may be used
Donepezil
Cholinesterase inhibitor
1) Compensate for loss of acetylcholine
2) Slows progression of disease
Side effects:
1)GI
2) Tacrine causes liver toxicity
Memantine
Noncompetative antagonist of NMDA receptor
1) Used for severe Alzheimer's
2) Reduce over stimuation of NMDA
Memantine

Side effects
1) Enhances side effects of L-Dopa
2) Agitation
3) UTI
4) Urinary incontinence
5) Insomnia
6) Diarrhea
Memantine

Drug interactions
Meperidine
Dextromethorphan